Results 1 to 10 of about 102,484 (264)

Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent. [PDF]

PLoS ONE, 2011
BACKGROUND: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. OBJECTIVE: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of
Julio Ponce, Xavier Calvet, Xavier Calvet, Marta Gallach, Marta Ponce, Esophagitis Study Group of the Asociación Española de Gastroenterología (AEG)   +5 more
doaj   +2 more sources

Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication O genótipo e o local no estômago de isolamento do Helicobacter pylori em pacientes com úlcera péptica não são fatores preditivos para o desenvolvimento de esofagite erosiva 1 ano após a erradicação da bactéria

Arquivos de Gastroenterologia, 2009
CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (CagA),
Carlos Alexandre Gonçalves Batista, Fernando Marcuz Silva, Ricardo Correa Barbuti, Jaime Natan Eisig, Rejane Mattar, Tomás Navarro-Rodriguez   +5 more
doaj   +2 more sources

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia

Journal of Research in Medical Sciences, 2022
Background: Chronic dyspepsia's symptoms are frequently seen in primary to tertiary healthcare in Indonesia. This study aimed to describe the potential usability of pepsinogen (PG) values in determining gastric mucosal conditions, including superficial ...
Muhammad Miftahussurur, Langgeng Agung Waskito, Ari Fahrial Syam, Iswan Abbas Nusi, I Nyoman Dewa Wibawa, Yudith Annisa Ayu Rezkitha, Kartika Afrida Fauzia, Gontar Alamsyah Siregar, Fardah Akil, Bradley Jimmy Waleleng, Alexander Michael Joseph Saudale, Azzaki Abubakar, Hasan Maulahela, Marselino Richardo, Abdul Rahman, Yoma Sari Namara, Eko Sudarmo, Pangestu Adi, Ummi Maimunah, Poernomo Boedi Setiawan, Dalla Doohan, Tomohisa Uchida, Astri Dewayani, Purwo Sri Rejeki, Titong Sugihartono, Yoshio Yamaoka   +25 more
doaj   +2 more sources

Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2023
Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the ...
Mun Young Cho, Yu Kyung Cho
doaj   +1 more source

Gastroprotective effects of methanolic extract of kratom leaves on gastric ulcer and reflux esophagitis in rats [PDF]

Songklanakarin Journal of Science and Technology (SJST), 2018
Kratom (Mitragyna speciosa (Korth.) Havil.) is a tropical tree indigenous to Thailand. In traditional medicine, it has been used to treat diarrhea, peptic ulcer, stomach ache or gastric upsets.
Somsmorn Chittrakarn, Nisaudah Radenahmad, Sujitra Kaewsara, Wandee Udomuksorn, Niwat Keawpradub, Pimpimol Phukpattaranont   +5 more
doaj   +1 more source

Acid Suppressive Drugs [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022
Histamine H2 receptor antagonists (H2RAs) suppress gastric acid production by blocking H2 receptors in parietal cells. Studies have shown that proton pump inhibitors (PPIs) are superior to H2RAs as a treatment for acid-related disorders, such as peptic ...
Cheol Min Shin
doaj   +1 more source

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children

Frontiers in Pharmacology, 2022
Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole.
Valeria Dipasquale, Giuseppe Cicala, Edoardo Spina, Claudio Romano   +3 more
doaj   +1 more source

Inverse time trends of peptic ulcer and reflux esophagitis show significant association with reduced prevalence of Helicobacter pylori infection

Annals medicus, 2020
Introduction Recent prevalence and trends of gastric/duodenal ulcer (GU/DU) and reflux esophagitis (RE) are inadequate. Methods We reviewed the records of consecutive 211,347 general population subjects from 1991 to 2015. Results During the 25 years, the
N. Yamamichi, Y. Yamaji, Takeshi Shimamoto, Yu Takahashi, K. Majima, R. Wada, T. Mitsushima, K. Koike   +7 more
semanticscholar   +1 more source

Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study

BMC Gastroenterology, 2013
BackgroundProton-pump inhibitors such as omeprazole are a standard treatment to prevent non-steroidal anti-inflammatory drug-induced upper gastrointestinal mucosal injuries.
T. Kuramoto, E. Umegaki, Sadaharu Nouda, Ken Narabayashi, Y. Kojima, Y. Yoda, K. Ishida, K. Kawakami, Yosuke Abe, T. Takeuchi, Takuya Inoue, M. Murano, S. Tokioka, K. Higuchi   +13 more
semanticscholar   +1 more source

Endoscopic evaluation of patients with dyspepsia in a secondary referral hospital in Egypt

Alexandria Journal of Medicine, 2015
Background: Dyspepsia is a common clinical problem. More than half of patients presenting with dyspepsia have no detectable lesion for their symptoms. The common organic causes of dyspepsia include peptic ulcer, esophagitis and cancer.
Ahmed Gado, Basel Ebeid, Aida Abdelmohsen, Anthony Axon   +3 more
doaj   +1 more source